期刊文献+

糖尿病患者血管性假血友病因子和D-二聚体变化分析 被引量:3

Study on the changes of von willebrand factor and D-dimer in diabetics
下载PDF
导出
摘要 目的 通过观察 2型糖尿病 (2 DM )及合并高血压患者血浆中血管假血友病因子 (VWF)及D 二聚体 (D D)的变化 ,探讨其与 2 DM血管病变的关系。方法 用酶联免疫吸附法测量 38例 2 DM患者 (2 DM组 )、2 0例合并高血压者和 2 5例正常者 (对照组 )外周血浆中VWF、D D水平变化。结果  2 DM患者血浆中VWF、D D(15 7 4 7± 4 5 77%和 0 5 1± 0 10mg/L)水平与对照组 (12 6 2 6± 2 0 4 2 %和 0 2 4± 0 0 9mg/L)相比明显升高 (P <0 0 1) ,2 DM合并高血压 (186 4 0± 2 5 5 6 %和 0 80± 0 2 8mg/L)则较单纯 2 DM增高(P <0 0 5 )。结论 VWF和D D升高与 2 DM血管病变密切相关 ,检测VWF和D D水平对防治 2 DM血管病变有重要临床意义。 Objective To study the clinical significance of the changes of von willebrand factor(VWF) and D-dimer(D-D) in patients with 2-type diabetes mellitus(2-DM) and with 2-DM and essential hypertension(EH).Methods 83 cases were divided into three groups including 38 cases of 2-DM,20 cases of 2-DM and EH and 25 cases of healthy controls,plasma VWF and D-D were measured in all cases.Results Compared with the control group,the concentration of VWF and D-D were found to be signifcantly higher in 2-DM group(157.47±45.77%,0.51±0.10mg/L vs 126.26±20.42%,0.24±0.09mg/L,P<0.01),however 2-DM and EH group more than 2-DM group(186.40±25.56%,0.80±0.28mg/L vs 157.47±45.77%,0.51±0.10mg/L,P<0.05).Conclusion There is significantly relationship between the higher concentration of VWF and D-D and vascular disease in 2-DM patients.It is important clinical value to measure plasma VWF and D-D for the prevention and treatment of vascular disturbance in 2-DM patients.
出处 《中国临床保健杂志》 CAS 2004年第2期94-95,共2页 Chinese Journal of Clinical Healthcare
基金 安徽省卫生厅科学研究基金资助课题 (编号 :2 0 0 2A0 36 )
关键词 血管性假血友病因子 D-二聚体 2型糖尿病 合并症 高血压 Type 2 diabetes mellitus Von willebrand factor D-dimer
  • 相关文献

参考文献4

  • 1[2]Lip GYH.Target organ damage and the prothombotie state in hypertension[J].Hypertension,2000,36:975-977.
  • 2王淑娟.关于选择血栓前状态实验诊断指标的建议[J].中华医学检验杂志,1998,21(5):305-307. 被引量:89
  • 3[4]Yamada T,Sato A,Nishimori T,et al.Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes[J].Diabetes Res Clin Part,2000,49:23-31.
  • 4[5]Varizi ND,Smith DH,Winer RL,et al.Coagulation and inhibitor and fibrinolytic protein in essential hypertension[J].J Am Soc Nephrol,1993,4:222-228.

共引文献88

同被引文献19

  • 1于宁 赵秀珍 等.原发性肾病综合征病人血浆D-二聚体的检测[J].青岛大学医学院学报,2000,35(2):130-130.
  • 2Nickolas TL, Radhakrishnan J, Appel GB. Hyperlipidemia and thrombotic complications in patients with membranousnephropathy. Seminars in Nephrology. 2003,23 (4),406- 1.
  • 3Couser WG. Pathogenesis of glomemlar damage in glomerulonephritis. Nephrology [ J ]. Dialysis,transplantation, 1998,13 ( Suppl 1 ), 10 - 5.
  • 4周同,李晓,陈晓农,董德长,朱立红,王鸿利.肾病综合征患者血浆D─二聚体变化[J].上海第二医科大学学报,1997,17(1):31-31. 被引量:9
  • 5AI-Mugeiren MM,Abdel Gader AG,AI-Rasheed SA,et al.Tissue factor pathway inhibitor in childhood nephrotic syndrome[J].Pediatr Nephrol,2006,21(6):771-777.
  • 6Sagripanti A,Barsotti G.Hypercoagulability,intraglomegular coagulatian,and thromboemlism in nephritic syndrome[J].Nephron,1995,70(3):271-281.
  • 7Nickoals TL,Radhakrishnan J,Appel GB.Hyperlipidem ia and thrombotic complicatipons in patients with membranous nephtopahty[J].Semin Nephrol,2003,23(4):406-411.
  • 8AI-Mugeiren MM, Abdd Gader AG,AI-Rasheed SA, et al. Tissue factor pathway inhibitor in childi-t3od nephrotic syndmme[J ]. Pediatr Nephrol, 2006,21(6) :771 - 777.
  • 9Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coag- ulation, and thromboemlism in nephrotic syndrome [ J ]. Nephron, 1995,70(3) :271 - 281.
  • 10Prandoni P. Acquired risk factors for venous thromboembolism in medical patients[J ]. Hematology Am Soc Hematol Educ Program, 2005,20 (1) : 458 - 461.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部